OTV

Stake is the first loyalty program to invest in renters. Stake creates a better relationship between owners and renters by rewarding staying, growing, and living in the neighborhoods we call home. Our proprietary rewards and investment platform invests in residents with return on rent, a monthly rent match that is invested in a real estate index fund. Residents use their returns to save for the things they love.

Scopio, LLC is an image search engine and licensing platform that focuses on trending images and videos from social media. Established in 2015 and headquartered in New York, the company utilizes artificial intelligence to facilitate the discovery and licensing of user-generated content. Its platform allows businesses, brands, non-governmental organizations, and live events to access a vast library of authentic and diverse photos, enabling them to customize messages and build their visual content libraries. Additionally, Scopio streamlines the copyright process for these images and videos, making it easier for users to search, license, publish, and analyze visual content sourced from social media.

Scopio Labs Ltd., established in 2015 and headquartered in Tel Aviv, Israel, specializes in the development of digital microscopes utilizing computational imaging technologies. The company's innovative diagnostics platform enhances clinical workflows and supports the screening of cancer, hematology, and cytology, as well as academic research and drug discovery. Scopio Labs provides a suite of fully digital diagnostic applications that facilitate faster, more accurate detection and diagnosis of blood-related diseases, allowing hematology laboratories to efficiently assess and analyze cell morphology. This technology aims to improve the consistency and efficiency of the diagnostic process across the continuum of care.

Developer of a behavioral health engagement platform intended to improve behavioral healthcare for underserved populations. The company's platform provides personalized care delivery services to integrate patients, providers and prescribers in the care cycle to manage the practice, enabling medical community to improve patient outcomes at minimal costs.

TytoCare Ltd. is a healthcare technology company that develops handheld devices and applications for on-demand medical examinations and remote diagnoses. Founded in 2012 and based in Netanya, Israel, with an office in New York, the company offers three main telehealth products: TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote care settings. These tools enable users to conduct self-examinations of various health conditions, such as ear infections, respiratory issues, and abdominal pain, by assessing the heart, lungs, skin, throat, ears, and body temperature. The platform facilitates virtual consultations by connecting patients with healthcare professionals, allowing for diagnosis and prescriptions as needed. TytoCare's technology incorporates a cloud-based data repository, analytics, and machine learning algorithms to enhance user experience and diagnostic accuracy. The company has established a strategic partnership with Novant Health to further its mission of making healthcare accessible and convenient.

MedaSense Biometrics Ltd. develops pain monitoring medical devices. Its PMD-200, an objective monitoring device that quantifies patients physiological response to pain. The company also offers NOL-egde Hub, a center of global collaboration aims to enhance pain research and the development of new products. Its serves to health care givers, researchers, patients, and industry. The company was incorporated in 2008 and is based in Ramat Gan, Israel with additional office in Longmont, Colorado.

Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through the advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays. It was founded in 2013 and is headquartered in San Francisco, California.

Scopio Labs Ltd., established in 2015 and headquartered in Tel Aviv, Israel, specializes in the development of digital microscopes utilizing computational imaging technologies. The company's innovative diagnostics platform enhances clinical workflows and supports the screening of cancer, hematology, and cytology, as well as academic research and drug discovery. Scopio Labs provides a suite of fully digital diagnostic applications that facilitate faster, more accurate detection and diagnosis of blood-related diseases, allowing hematology laboratories to efficiently assess and analyze cell morphology. This technology aims to improve the consistency and efficiency of the diagnostic process across the continuum of care.

TytoCare Ltd. is a healthcare technology company that develops handheld devices and applications for on-demand medical examinations and remote diagnoses. Founded in 2012 and based in Netanya, Israel, with an office in New York, the company offers three main telehealth products: TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote care settings. These tools enable users to conduct self-examinations of various health conditions, such as ear infections, respiratory issues, and abdominal pain, by assessing the heart, lungs, skin, throat, ears, and body temperature. The platform facilitates virtual consultations by connecting patients with healthcare professionals, allowing for diagnosis and prescriptions as needed. TytoCare's technology incorporates a cloud-based data repository, analytics, and machine learning algorithms to enhance user experience and diagnostic accuracy. The company has established a strategic partnership with Novant Health to further its mission of making healthcare accessible and convenient.

HyGIeaCare, Inc. provides various solutions and services for gastroenterologists to deliver GI outcomes for their patients in the United States and internationally. The company offers HyGIeaCare Prep system, a prescription medical device for colon cleansing, when medically indicated, such as before radiologic or endoscopic examinations; and HyGIeaCare Prep procedures and services. It operates a chain of HyGIeaCare centers. The company is based in Austin, Texas.

Emedgene Technologies Ltd., based in Mazor, Israel, specializes in clinical genetic interpretation and diagnostics for individuals and families affected by rare Mendelian diseases. As the first fully automated genetic interpretation platform, Emedgene addresses the challenges posed by traditional, manual interpretation processes that hinder the adoption of genetic-based healthcare. Utilizing natural language processing, the platform continuously updates its knowledge base by analyzing new genetic publications. It employs machine learning algorithms to identify pathogenic variants, facilitating clearer clinical decision-making. By implementing Emedgene's technology, clinical laboratories enhance operational efficiency, reduce the time required for interpretation and reporting, and improve diagnostic yield without increasing personnel. Additionally, research organizations benefit from accelerated genomic-driven discoveries through the platform’s capabilities.

HARBO Technologies Ltd. specializes in providing innovative solutions to prevent and mitigate the effects of oil spills. The company has developed the T-Fence system, a compact, lightweight booming solution that can be rapidly deployed by as few as two personnel at the spill source, whether on a vessel, at a port, or at an oil terminal. This system is designed for immediate use, effectively blocking the spread of oil spills in various environments, including remote locations with minimal logistical requirements. Founded in 2012 and based in Tel Aviv, Israel, HARBO Technologies caters to a diverse range of clients, including large ships, oil rigs, coast guard units, and coastal infrastructure facilities, aiming to reduce the negative impacts of marine oil spills while enhancing response efficiency.

Gauzy is currently a leading provider of turnkey liquid crystal glass projects, installing laminated LC films in different applications such as home appliances, architecture, construction, automotive industry and many other segmented markets. Their patent pending innovative control technologies enable us to handle glass like never before – Dim glass with numerous stages of transparency, create in-glass blinds, insert transparent solar cells into glass windows, and achieve various glass related innovations in the automotive and aviation industries.

Scopio Labs Ltd., established in 2015 and headquartered in Tel Aviv, Israel, specializes in the development of digital microscopes utilizing computational imaging technologies. The company's innovative diagnostics platform enhances clinical workflows and supports the screening of cancer, hematology, and cytology, as well as academic research and drug discovery. Scopio Labs provides a suite of fully digital diagnostic applications that facilitate faster, more accurate detection and diagnosis of blood-related diseases, allowing hematology laboratories to efficiently assess and analyze cell morphology. This technology aims to improve the consistency and efficiency of the diagnostic process across the continuum of care.

MedaSense Biometrics Ltd. develops pain monitoring medical devices. Its PMD-200, an objective monitoring device that quantifies patients physiological response to pain. The company also offers NOL-egde Hub, a center of global collaboration aims to enhance pain research and the development of new products. Its serves to health care givers, researchers, patients, and industry. The company was incorporated in 2008 and is based in Ramat Gan, Israel with additional office in Longmont, Colorado.

HARBO Technologies Ltd. specializes in providing innovative solutions to prevent and mitigate the effects of oil spills. The company has developed the T-Fence system, a compact, lightweight booming solution that can be rapidly deployed by as few as two personnel at the spill source, whether on a vessel, at a port, or at an oil terminal. This system is designed for immediate use, effectively blocking the spread of oil spills in various environments, including remote locations with minimal logistical requirements. Founded in 2012 and based in Tel Aviv, Israel, HARBO Technologies caters to a diverse range of clients, including large ships, oil rigs, coast guard units, and coastal infrastructure facilities, aiming to reduce the negative impacts of marine oil spills while enhancing response efficiency.

Via Surgical Ltd. develops novel surgical fixation technologies for mesh placement in hernia repair. It offers FasTouch, a system that provides deployable suture fixation for hernia repair. The company was founded in 2011 and is based in Amirim, Israel.

mPharma Data, Inc. is a technology-driven company based in Accra, Ghana, with an additional location in Lexington, Massachusetts. Founded in 2013, it focuses on improving access to high-quality medications in emerging markets by connecting physicians, pharmacies, and patients through its application. The company aggregates real-time market data on prescription trends, drug consumption, and adverse reactions, providing valuable insights to pharmaceutical manufacturers, distributors, and governments. mPharma offers a pharmacy network application that centralizes inventories from multiple pharmacies, enabling easier drug searches for physicians and patients. Additionally, the company provides subscription-based data analytics for actionable insights on drug consumption and diagnosis, along with prescription management tools to assist healthcare providers in locating various medicines. By partnering with drug manufacturers, insurance companies, and governments, mPharma aims to facilitate affordable access to essential medications for patients.

Scopio Labs Ltd., established in 2015 and headquartered in Tel Aviv, Israel, specializes in the development of digital microscopes utilizing computational imaging technologies. The company's innovative diagnostics platform enhances clinical workflows and supports the screening of cancer, hematology, and cytology, as well as academic research and drug discovery. Scopio Labs provides a suite of fully digital diagnostic applications that facilitate faster, more accurate detection and diagnosis of blood-related diseases, allowing hematology laboratories to efficiently assess and analyze cell morphology. This technology aims to improve the consistency and efficiency of the diagnostic process across the continuum of care.

CU-BX provides high-accuracy measurements of driver health parameters, fatigue, stress, and comfort. Our patented technology maintains high-level accuracy across all road and lighting conditions and is agnostic to clothing and other accessories such as masks, sunglasses, headwear, etc. CU-BX works closely with all key automotive players (OEMs, Tier-1 and Tier-2 manufacturers) on providing driver monitoring systems (DMS) as well as aftermarket solutions. See our 1-pager here: https://www.dropbox.com/s/a0bp4dmmcwlwoe0/CU-BX_Automotive_OnePager.pdf?dl=0